Can the Body's own 'Off Switch' for inflammation predict who survives severe infection?
NCT ID NCT07353970
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study will follow 300 adults with severe infections in the ICU to see how levels of specialized pro-resolving mediators (SPMs)—natural molecules that help stop inflammation—change over time. Researchers will use blood samples already collected during routine care, so no extra tests or treatments are given. The goal is to find patterns that could help doctors identify high-risk patients earlier and improve care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors identify high-risk patients with severe infections earlier, potentially guiding more personalized care.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly test any new drug or therapy, and results may not lead to immediate changes in patient care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL ILLNESS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- AI may predict transfusion needs to shield ICU patients from organ failure
- A simple blood test trend may flag ICU patients at risk
- Can brain waves predict thinking problems after sepsis?
- Could a simple CT scan reveal which ICU cancer patients are at highest risk?